SABS icon

SAB Biotherapeutics
SABS

Overview Fund Trends Analyst Outlook Journalist POV

24 hedge funds and large institutions have $15.2M invested in SAB Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

86% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 21

Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$348K
2
+$245K
3
+$126K
4
BlackRock
BlackRock
New York
+$4.88K
5
Marshall Wace
Marshall Wace
United Kingdom
+$2.91K

Top Sellers

1
-$1.63M
2
-$555K
3
-$60.5K
4
State Street
State Street
Massachusetts
-$55.9K
5
Mariner
Mariner
Kansas
-$47.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
1
2